| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK-1292263 |
|---|
| Description | GSK-1292263 is a novel GPR119 receptor agonist and is used for the treatment of type 2 diabetes. GSK1292263 improves glucose regulation in animal models of diabetes, but has no effect on plasma glucose in type 2 diabetics. MW: 456.56. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole |
|---|
| Gene, Accession, CAS # | CAS: 1032823-75-8 |
|---|
| Catalog # | B1556-25 |
|---|
| Price | |
|---|
| Order / More Info | GSK-1292263 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|